Response to Letters Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"

被引：0
|
作者：
Guazzi, Marco [1 ]
Vicenzi, Marco [1 ]
Arena, Ross [2 ]
Guazzi, Maurizio D. [3 ]
机构：
[1] Univ Milan, Cardiopulm Unit, Milan, Italy
[2] Univ New Mexico, Dept Phys Therapy, Albuquerque, NM 87131 USA
[3] Univ Milan, Dept Cardiol, Milan, Italy
来源：
CIRCULATION | 2012年 / 125卷 / 08期
关键词：
D O I：
10.1161/CIRCULATIONAHA.111.072090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E409 / E410
页数：2
相关论文
共 50 条
  • [1] Letter by Jamous Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"
    Jamous, Fady G.
    CIRCULATION, 2012, 125 (08) : E407 - E407
  • [2] Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
    Guazzi, Marco
    Vicenzi, Marco
    Arena, Ross
    Guazzi, Maurizio D.
    CIRCULATION, 2011, 124 (02) : 164 - U120
  • [3] Letter by Forfia and Borlaug Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"
    Forfia, Paul R.
    Borlaug, Barry A.
    CIRCULATION, 2012, 125 (08) : E408 - E408
  • [4] Letter by Gordon et al Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"
    Gordon, Brian
    McDiarmid, Adam
    MacGowan, Guy
    CIRCULATION, 2012, 125 (08) : E406 - E406
  • [5] Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention
    Guazzi, Marco
    van Heerebeek, Loek
    Paulus, Walter J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (03) : 337 - 339
  • [6] Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
    Ovchinnikov, Artem
    Potekhina, Alexandra
    Belyavskiy, Evgeny
    Ageev, Fail
    PHARMACEUTICALS, 2022, 15 (08)
  • [7] Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Target for Therapy?
    Waxman, Aaron B.
    CIRCULATION, 2011, 124 (02) : 133 - 135
  • [8] Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction"
    Mohammed, Selma F.
    Redfield, Margaret M.
    CIRCULATION, 2015, 132 (16) : E206 - E206
  • [9] Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
    Redfield, Margaret M.
    Chen, Horng H.
    Borlaug, Barry A.
    Semigran, Marc J.
    Lee, Kerry L.
    Lewis, Gregory
    LeWinter, Martin M.
    Rouleau, Jean L.
    Bull, David A.
    Mann, Douglas L.
    Deswal, Anita
    Stevenson, Lynne W.
    Givertz, Michael M.
    Ofili, Elizabeth O.
    O'Connor, Christopher M.
    Felker, G. Michael
    Goldsmith, Steven R.
    Bart, Bradley A.
    McNulty, Steven E.
    Ibarra, Jenny C.
    Lin, Grace
    Oh, Jae K.
    Patel, Manesh R.
    Kim, Raymond J.
    Tracy, Russell P.
    Velazquez, Eric J.
    Anstrom, Kevin J.
    Hernandez, Adrian F.
    Mascette, Alice M.
    Braunwald, Eugene
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1268 - 1277
  • [10] EFFICACY OF PHOSPHODIESTERASE-5 INHIBITOR IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A META-ANALYSIS
    Bajaj, Anurag
    Nanavaty, Sukrut
    Coppola, John
    Tiwari, Hemant
    Patel, Tejas
    Pancholy, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 704 - 704
12345